This activity is intended for obstetricians/gynecologists/women's health clinicians, pediatricians, diabetologists/endocrinologists, family medicine/primary care practitioners, internal medicine clinicians, nurses, physician assistants, and other members of the health care team who treat and manage overweight girls who may be at risk for menstrual problems in adulthood.
The goal of this activity is that learners will be better able to describe the association between childhood and adolescent body mass index and risk for premenstrual disorders in young adulthood, based on a prospective cohort study of US female participants in the Growing Up Today Study (GUTS: 1996-2013).
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.
Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 4/15/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / ABIM MOC / CE Released: 4/15/2022
Valid for credit through: 4/15/2023
processing....
Data suggests that more than two-thirds of premenstrual disorders (PMDs) have symptom onset during the teen years. Premenstrual disorders can include premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). PMDD is more disabling due to the predominant psychological symptoms and social functioning problems. Few risk factors in early life have been identified for PMD development.
Higher body mass index (BMI) may be a consequence of premenstrual symptoms rather than a contributor. Prospective data are needed to clarify a potential causal relationship between childhood BMI and subsequent risk for PMDs.
Above-normal body mass in childhood is a risk factor for premenstrual disorders in adulthood, a new study has found.
The results suggest that maintaining a normal weight as a preadolescent may lower the burden of premenstrual disorders later on, according to the researchers, whose study was published online March 8 in JAMA Network Open.[1]
"Healthcare providers should be aware of the risk of premenstrual disorders among children with bigger body mass and educate the girls and their parents about the premenstrual symptoms," such as mood swings, hypersensitivity, insomnia, fatigue, and food cravings, said Donghao Lu, MD, PhD, from the Karolinska Institute in Stockholm, Sweden, who led the study.
Although prior cross-sectional studies have shown correlations between BMI and premenstrual disorders, whether one condition leads to the other has been unclear.
"The thinking was that premenstrual disorders might contribute to weight gain because premenstrual syndrome usually includes cravings and mood changes," Chighaf Bakour, MD, PhD, University of South Florida, Tampa, who authored an accompanying editorial, told Medscape Medical News.[2]
Identifying PMS and PMDDTo examine the association between childhood body size and the risk for premenstrual disorders in young adulthood, Dr Lu and colleagues analyzed data from 6,524 US women participating in the Growing Up Today Study (GUTS), which includes children of participants in the Nurses' Health Study II.
The investigators enrolled more than 16,800 children aged 9 to 14 years in the first phase of GUTS in 1996. In a second phase in 2004, researchers recruited nearly 11,000 other children aged 9 to 16 years. Participants reported their height and weight on questionnaires. In 2013 they completed a questionnaire about premenstrual symptoms.
About 15% met criteria for premenstrual disorders, including premenstrual syndrome and premenstrual dysphoric disorder, a more disabling form in which psychologic symptoms predominate and impair social functioning.
Baseline BMI, at an average age of 12.7 years, was positively associated with the risk for premenstrual disorders at a mean age of 26 years, with a risk ratio of 1.09 per unit of BMI z score (95% confidence interval [CI], 1.03-1.15).
The researchers also found a trend of increasing premenstrual symptom severity across BMI categories.
"Obesity was associated with a higher burden of premenstrual symptoms (β = 0.27; 95% CI, 0.09-0.44) compared with normal BMI for age," they write. After adjusting for potential mediators like age at menarche, obesity's association with symptoms remained significant but "slightly attenuated," they say.
Women with premenstrual disorders experienced menarche slightly earlier, on average, than women without the conditions (12.7 vs 12.8 years). They also were more likely to report experiences of childhood abuse (27.8% vs 21.3%), to smoke, and to have anxiety, depression, and disordered eating based on self-reported diagnoses, medication use, or reported symptoms.
Prior studies have shown that early menarche and adverse childhood experiences also are associated with increased risk for premenstrual disorders, Dr Lu noted.[3,4]
Opportunity for Intervention?The researchers speculated that the interplay between fat and sex hormones could contribute to the increased risk. Another possibility, they added, is that an inflammatory response to obesity somehow triggers the development of premenstrual disorders.
But many women with PMDs may have had normal body mass as children. "Of course, we don't believe larger body size is the only player here," Dr Lu told Medscape Medical News.
The study does not establish that overweight or obesity causes premenstrual disorders, Dr Bakour writes in her commentary to the study. Other, unmeasured variables related to adverse childhood environments or diet, for example, might contribute to the development of both weight gain and premenstrual syndrome.
The next step, she said, would be to look at what might contribute to both disorders: "Something like depression, mental illness, or toxic stress would contribute to overweight and also increase premenstrual disorders," she told Medscape Medical News. The study also paves the way for interventional studies to test whether weight management can reduce the incidence or burden of premenstrual disorders.
The study was supported by Swedish Research Council grants. The Growing Up Today Study was supported by the National Institutes of Health. Study coauthors disclosed grants from the National Institutes of Health and work on a study for the Swedish Inflammatory Bowel Disease Register, which receives funding from Janssen. Dr Bakour has disclosed no relevant financial relationships.
JAMA Netw Open. Published online March 8, 2022.